Cite

HARVARD Citation

    Biancone, L. et al. (2009). Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFα reduce colitis-associated colorectal carcinogenesis?. Gut. 58 (12), p. 1703. [Online]. 
  
Back to record